Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption

Romanian Journal of Gastroenterology

Volumn 12, Issue 3, 2003, Pages 183-187

  Vǎdan, Roxana ^a   Gheorghe, Liana ^a   Becheanu, Gabriel ^a   Iacob, Ražvan ^a   Iacob, Speranţa ^a   Gheorghe, Cristian ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Chronic viral C hepatitis alcohol; Liver fibrosis; Steatosis

Indexed keywords

ALCOHOL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BILE DUCT INJURY; CELL AGGREGATION; CHRONIC HEPATITIS; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LYMPHOID CELL AGGREGATION; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS;

ALCOHOL DRINKING; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 0141850416     PISSN: 12214167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rubbia-Brandt L, Quadri R, Abid K et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000; 33: 106-115.
2. Hourigan LT, Macdonald GA, Purdie D et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.
3. Marcellin P, Asselah T, Boyer N et al. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36; S47-S56.
4. Bellentani S, Pozzato G, Saccoccio G et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999; 44: 874-880.
5. Harris HE, Ramsay ME, Andrews N et al. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002; 324: 450-453.
6. Alter MJ, Kruszon-Moran D., Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
7. Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lessons from the Dionysos study. J Hepatol 2001; 35: 531-537.
8. Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999; 31: 17-24.
9. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C 2002. Hepatology 2002; 36: S3-S20.
10. Adinolfi LE, Gambardella M, Andreana A et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-1364.
11. Castera L, Hezode C, Roudot-Thoraval F et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003; 52: 288-292.
12. Coates RA, Halliday ML, Rankin JG et al. Risk of fatty liver infiltration of cirrhosis of the liver in relation to ethanol consumption: a case control study. Clin Invest Med 1986; 9: 26-32.
13. Poynard T., Bedossa P, Opolon P. for the Obsvire, Metavir, Clinivir and Dosvire groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
14. Poynard T, Ratziu V, Charlotte F et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34: 730-739.
15. Sefarty L, Poujol-Robert A, Carbonell N et al. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C. Am J Gastroenterol 2002; 97: 1807-1812.
16. Negro F. Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always. Hepatology 2002; 36: 1050-1052.
17. Kumar D, Farrell GC, Fung C et al. Hepatitis C virus genotype 3 is cytopathic to hepatocytes. Reversal of hepatic steatosis after sustained therapeutic response. Hepatology 2002; 36: 1266-1272.
18. Adinolfi LE, Utili R, Andreana A et al. Serum HCV RNA levels correlate with histological liver damage and coneur with steatosis in progression of chronic hepatitis C. Dig Dis Sci 2001; 46: 1677-1683.
19. Hui JM, Kench J, Farrell GC et al. Genotype specific mechanism for hepatic steatosis in chronic hepatitis C infection. J Gastroenterol Hepatol 2002; 17: 873-881.
20. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-992.